Victory Capital Management Inc Revance Therapeutics, Inc. Transaction History
Victory Capital Management Inc
- $95.7 Billion
- Q4 2024
A detailed history of Victory Capital Management Inc transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 11,788 shares of RVNC stock, worth $30,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,788
Previous 12,073
2.36%
Holding current value
$30,295
Previous $31,000
3.23%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding RVNC
# of Institutions
201Shares Held
80.8MCall Options Held
2.26MPut Options Held
5.48M-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA5.94MShares$15.3 Million9.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$14.5 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I05.1MShares$13.1 Million0.78% of portfolio
-
Fil LTD Hamilton, D04.2MShares$10.8 Million0.01% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...